MENUCLOSE

 

Connect with us

Tag : clinical trials

What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay

Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials. The founder and CEO of OncoBay Clinical, Krystyna shares her efforts to break the mold when it comes to cancer research, and explores OncoBay's "just in time"

When Seeking Diversity during Site Selection, Look Beyond Historical Data to Discover Untapped Patient Populations

We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company is disrupting the industry's approach to site selection. The company is headquartered in Paris, France, with US operations based in New York City, NY. Here are some of the most interesting excerpts from our discussion: ArcheMedX: You

Choosing a Solution to Train Clinical Trial Site Staff Virtually? Start With this Checklist.

Choosing the right way to train clinical trial staff is complex and exhausting under normal circumstances. Today’s immense pressure to accommodate new virtual working styles across investigator meetings, site selection, and site initiation visits magnifies those challenges. As we revealed in our recent report, clinical operations leaders are adopting virtual tools

Helping Sites and Teams Make the Shift to Decentralized Trials: Interview with Paul Evans of Velocity Clinical Research

Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, to discuss best practices for sites making the shift toward decentralized trials. Paul shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to

The Evolving Role of Sites in Virtual & Decentralized Trials: Interview with Mary Costello of Medable

Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how clinical research site management is changing - and marching towards sites being capable with decentralized clinical trials - in the face of the pandemic. Mary’s more than 20 years of diverse experience in the

Demystifying Decentralized Clinical Trials: Interview with R’Kes Starling of Reveles Clinical

R'Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss how decentralized clinical trials (DCTs) can expand access to clinical trials and promote patient participation. He shares the personal experiences that motivated him to found Reveles. R'Kes also recounts a poignant story of a

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North American Operations at SCOPE International, an independent full-service CRO serving pharma, biotech, and medical device clients across the US and Europe. The company is headquartered in Mannheim, Germany, with US operations based in Pittsburgh, PA.

Conversations in Clinical Trial Readiness: Kunal Sampat of Ceribell

Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders